Blog
Best Ecommerce Platforms for Research Peptide Brands in 2026
Choosing a platform for a peptide brand? Compare Swell, Shopify, BigCommerce, WooCommerce and commercetools on processor rules, FDA status and fees in 2026.

The best ecommerce platform for a peptide brand is the one that can run the payment processor that approved you, handles subscriptions natively, and gives you full control over product copy and checkout. As of November 2, 2026, WooPayments explicitly prohibits peptides, Shopify Payments and Braintree exclude pseudo-pharmaceuticals, and Stripe prohibits incorrectly labeled research chemicals. Most research-peptide brands therefore need a high-risk merchant account, and the platform decision comes down to which one can connect it cleanly.
This guide covers both research peptides and cosmetic or wellness peptides (skincare serums, collagen peptides), because payment providers and FDA treat them very differently. Platform policies and processor lists below were checked on each provider's own site on November 2, 2026. Regulatory facts are dated and linked to FDA or the statute. None of this is legal advice; rules vary by product and state, so check with counsel.
Key Takeaways
- The processor decides, not the platform. Every platform here can host a peptide catalog. Whether you can take cards is up to the payment provider's underwriting, and approval can be reviewed or withdrawn later.
- Swell fits brands that want native subscriptions, several gateways running at once and custom data for lot numbers and COAs. Built-in card gateways are Stripe, Authorize.Net, Braintree, Saferpay and QuickPay; other processors need a developer-built payment extension app and that processor's own approval.
- BigCommerce connects to a long gateway list, but providers outside its embedded list carry a 0.6% to 2% Open Payment Provider fee on self-serve plans, and subscriptions need an app.
- WooCommerce gives full control, but WooPayments prohibits peptides, so you'll use a third-party gateway plugin and the paid Subscriptions extension.
- Shopify allows one credit card provider at a time and charges 0.2% to 2% when you don't use Shopify Payments, which excludes pseudo-pharmaceuticals.
- "Research use only" labels don't settle FDA status. In 2026 warning letters, FDA treated RUO peptides as unapproved new drugs when the seller's website showed intended human use.
Quick Comparison: Ecommerce Platforms for Peptide Brands (November 2026)
| Platform | Card payments for peptide sellers | Subscriptions | Platform fee tied to payments | Best for |
|---|---|---|---|---|
| Swell | Built-in Stripe, Authorize.Net, Braintree, Saferpay, QuickPay; other processors via a payment extension app; several gateways at once | Native | Plan sales ceiling; 2% to 0.4% on sales above it | Brands with a processor lined up that want native subscriptions and custom data |
| BigCommerce | Large gateway list; merchant responsible for regulated-product compliance | App or specific gateway required | 2% / 1% / 0.6% Open Payment Provider fee outside the embedded list | Hosted stores that can use an embedded provider |
| WooCommerce | WooPayments prohibits peptides; third-party gateway plugins | Paid extension ($279/year) | None from WooCommerce core | WordPress teams that will own hosting and security |
| commercetools | Custom integration with any provider | Recurring Orders (payment configuration in beta) | Quote-only, order-based pricing | Enterprises with engineering teams |
| Shopify | Shopify Payments excludes pseudo-pharmaceuticals; one credit card provider at a time | Free Shopify Subscriptions app; limited gateway list | 2% / 1% / 0.6% / 0.2% third-party fee | Cosmetic peptide brands that qualify for Shopify Payments |
Research Peptides vs. Cosmetic Peptides
Research peptides (BPC-157, TB-500, CJC-1295, ipamorelin, GLP-1 analogues sold as research chemicals) are the high-risk case. They aren't FDA-approved drugs, payment providers group them with research chemicals or pseudo-pharmaceuticals, and FDA judges them by how they're marketed rather than by the label.
Cosmetic peptides (copper peptides in serums, signal peptides in eye creams, collagen peptides) are mainstream products. FDA classifies a product by its intended use, and "certain claims may cause a product to be considered a drug" even if it's sold as a cosmetic. A serum marketed to improve the look of skin is typically a cosmetic; claims to heal tissue, treat a condition or change how the body works are drug claims. Under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), manufacturers must register facilities and responsible persons must list each cosmetic product with FDA; FDA began enforcing those requirements on July 1, 2024.
Peptide supplements sit in between. A substance approved as a drug, or authorized for investigation as a new drug with substantial clinical investigations under way, generally can't be sold as a dietary supplement unless it was marketed as a supplement or food first (21 U.S.C. 321(ff)(3)(B)). On August 24, 2026, FDA warned a seller that a peptide supplement was adulterated because it contained a new dietary ingredient.
Payment Processing for Peptide Brands: What Providers Say (November 2026)
Payments are the hardest part of selling peptides online. None of the mainstream lists below except WooPayments uses the word "peptide", but most cover the category through research-chemical, pseudo-pharmaceutical, health-claim or prescription-drug entries. Each provider makes its own call on your business.
| Provider | What its policy says (checked Nov 2, 2026) | What it means for peptide sellers |
|---|---|---|
| Stripe | Prohibits "incorrectly labeled research chemicals" and pseudo-pharmaceuticals or nutraceuticals "that are not safe or make harmful claims"; card-not-present prescription products are restricted | Research peptides get reviewed against these entries; get written confirmation before launch |
| PayPal | Prohibits products that "present a risk to consumer safety"; prescription items need pre-approval | Case by case; pre-approval needed for anything prescription-adjacent |
| Braintree | Prohibits "pseudo pharmaceuticals" and prescription drugs | Not a fit for research peptides |
| Shopify Payments | Prohibits pseudo-pharmaceuticals and products with health claims not verified by a regulator; lists prescription drugs as prohibited | Research peptides need a third-party processor |
| WooPayments | Names "peptides and other research chemicals" as not allowed | Not available for research peptides |
| Square | Prohibits online pharmacies and "high-risk products and services" | Not a fit for research peptides |
| Affirm and Amazon Pay | Affirm lists pseudo-pharmaceuticals as unsupported; Amazon Pay prohibits prescription drugs and "miracle cure" products and applies its supplement rules | Don't plan on BNPL or wallets for research peptides |
| Authorize.Net | A gateway that requires a merchant account from a merchant service provider; sold as an all-in-one plan or gateway-only | The merchant account provider's underwriting decides |
Sources: Stripe, PayPal, Braintree, Shopify Payments, WooPayments, Square, Affirm, Amazon Pay, Authorize.Net.
How high-risk merchant accounts work. Brands that can't use a mainstream processor apply to a high-risk acquirer or ISO, which underwrites the business and issues a merchant account. That account then runs through a payment gateway such as Authorize.Net. Expect underwriting to ask for your product list, website, refund and shipping policies, processing history and supplier documentation, and to set pricing, reserves and chargeback limits for your account specifically. Card networks also apply extra monitoring to some categories; the Visa Core Rules (October 2026 edition) require acquirers to register merchants Visa classifies as high-integrity risk, a group that covers card-absent pharmacy sales.
Two practical rules follow. Apply for the merchant account before you build the store, because the processor determines which gateway the platform has to support. And plan for a second processor, because a single termination can stop sales.
FDA Status of Research Peptides and Compounding (as of November 2, 2026)
"Research use only" and "not for human consumption" labels
FDA looks at the whole website, not only the label. In a March 31, 2026 warning letter to a seller of retatrutide and tirzepatide labeled "Research Use Only", FDA said "evidence obtained from your website establishes that your products are intended to be drugs for human use" and called them unapproved new drugs. A batch of letters dated August 24, 2026 made the same finding for sellers of semaglutide, tirzepatide, retatrutide, SS-31, tesamorelin and PT-141, and treated bundled bacteriostatic water as a means to prepare an injectable drug for human use. FDA's Import Alert 66-41 on unapproved new drugs lists melanotan, GHRP-6 and ipamorelin products.
Peptides and pharmacy compounding
Under section 503A of the FD&C Act, a pharmacy can compound from a bulk drug substance only if it has a USP or NF monograph, is a component of an FDA-approved drug, or appears on FDA's 503A bulks list. While that list is built, FDA's interim policy holds off on enforcement only for substances in category 1.
FDA's category 2 safety-risk page (current as of April 22, 2026) now lists BPC-157, TB-500, CJC-1295, AOD-9604, KPV, MOTs-C, selank, semax, epitalon, thymosin alpha-1 and others as "previously in category 2" because the nominators withdrew them. That doesn't place them in category 1. GHRP-2, GHRP-6 and ipamorelin acetate remain in category 2 for 503B outsourcing facilities, and kisspeptin-10 for 503A.
FDA's Pharmacy Compounding Advisory Committee met July 23-24, 2026 on BPC-157, KPV, TB-500, MOTs-C, emideltide, Semax and epitalon for the 503A bulks list. FDA's briefing document proposed not adding any of them. As of November 2, 2026, FDA has not posted minutes or a decision, and its 503A nominations list (updated May 14, 2026) says it intends to consult the committee on GHK-Cu before the end of February 2027.
Compounded GLP-1s
FDA declared the tirzepatide shortage resolved on October 2, 2024 (reaffirmed December 19, 2024) and the semaglutide shortage resolved on February 21, 2025; the grace periods for compounding them ended in 2025, per FDA's GLP-1 compounding policy page. On March 3, 2026, FDA warned 30 telehealth companies about compounded GLP-1 marketing, and on April 30, 2026 it proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list. As of November 2, 2026, no final decision on that proposal has been published.
Labeling and "Not for Human Consumption" Practice
Research-peptide sellers commonly label products "for research use only, not for human consumption", require buyers to confirm research use at checkout, publish certificates of analysis by lot, and avoid dosing, injection or health-benefit content. The warning letters above show FDA reads all of it together: product names, blog posts, customer reviews, support replies and bundled supplies. A label that contradicts the rest of the site doesn't help.
For platform choice, that means you need control over every surface: product templates, review moderation, transactional emails, checkout fields for attestations, and the ability to store lot numbers and COA links per order. Have counsel review your labels and site copy before launch, and again when FDA publishes new actions.
1. Swell
Swell is an API-first commerce platform with a hosted admin, a visual storefront editor and a full headless option. For peptide brands the relevant parts are payments, subscriptions and how much of the catalog and checkout you can shape yourself.
Payments. Swell's built-in card gateways are Stripe, Authorize.Net, Braintree, Saferpay and QuickPay, and a store can connect multiple gateways at the same time. For research peptides, Braintree's policy prohibits pseudo-pharmaceuticals and Stripe's covers mislabeled research chemicals and harmful-claim nutraceuticals (see the table above). Authorize.Net is the built-in gateway that most often fits a high-risk merchant account: it's a gateway that needs a merchant account, and the merchant account provider decides whether to approve your business. Processors that aren't built in, such as NMI, PaymentCloud, Bankful or eMerchantBroker, are not integrated with Swell. A developer can connect one of them through a Swell payment extension app, subject to that processor's own approval of your business. Approval is always the payment provider's decision.
Terms. Section 4.4 of Swell's terms requires that anything you sell be lawful where you offer, sell and ship it, makes you responsible for licenses and compliance, and notes that processors and other providers apply their own rules, which are often stricter. Swell can act on products it determines are unlawful or create legal or regulatory risk.
Subscriptions. Recurring billing is built in: subscription plans sold alongside one-time items, monthly, yearly or custom schedules, pause and resume, and automatic retry of failed payments. No separate subscription app is required.
Catalog and compliance data. Swell's pricing page lists unlimited products and variants. Custom data models let you store batch or lot numbers, certificate-of-analysis links and research-use attestations on products, orders or customers, and expose them through the API to your storefront and fulfillment tools.
Pricing (as of November 2026). Starter $29, Basic $79, Standard $299 and Unlimited $2,250 per month, billed yearly. Each plan includes trailing-12-month sales up to $50K, $250K, $1M or $5M, with a fee of 2%, 1.5%, 1% or 0.4% on sales above that ceiling. Custom pricing applies above $10M a year. See swell.is/pricing. Payment processing fees are charged separately by your processor.
Best for: peptide and peptide-skincare brands that have a processor lined up (or are applying for one) and want subscriptions, multiple gateways and room to build compliance data into the catalog without stacking apps.
2. BigCommerce
BigCommerce is a hosted SaaS platform with self-serve plans and an enterprise tier. Its acceptable use policy (revised July 31, 2025) doesn't name peptides or supplements; it makes merchants solely responsible for ensuring regulated products comply with applicable law. Payment eligibility is decided by whichever provider you connect.
As of November 2026, BigCommerce pricing is Core $29, Growth $79 and Scale $299 per month billed annually, each with a trailing-12-month GMV cap. Since June 1, 2026, orders processed through a provider outside BigCommerce's embedded provider list carry an Open Payment Provider fee of 2.0% (Core), 1.0% (Growth) or 0.6% (Scale). The embedded list includes Stripe, PayPal Braintree, Adyen, Worldpay, Global Payments, BlueSnap and Bankful, among others. A high-risk acquirer that isn't on the list means paying that fee on top of processing.
BigCommerce allows 600 variants per product. Recurring billing needs an app or a specific payment gateway, so check that your subscription app works with the processor that approved you.
Best for: brands that want a hosted platform with a broad gateway list and can either use an embedded provider or absorb the Open Payment Provider fee.
3. WooCommerce
WooCommerce is a free, open-source plugin for WordPress that you host yourself, so the platform layer doesn't decide what you sell. Its own payment product does: WooPayments' prohibited list names "peptides and other research chemicals", "pseudo-pharmaceuticals" and "supplements supported by unsubstantiated claims". Peptide sellers on WooCommerce install a third-party gateway plugin for a processor that has approved them.
Recurring billing needs the WooCommerce Subscriptions extension, listed at $279 for one year as of November 2026, and the extension has to support your gateway plugin. Hosting, PCI scope, security patches and backups are your responsibility. If you host on WordPress.com rather than your own server, its store guidelines also apply.
Best for: teams with WordPress experience who want full control of the stack and will own its maintenance.
4. commercetools
commercetools is an enterprise, API-first platform with no storefront included. Its pricing page doesn't publish prices; pricing is order-based and quoted on request. Products are limited to 100 variants by default, which commercetools can raise per project after reviewing performance impact.
Recurring Orders became generally available in September 2025; as of November 2026 the recurring payment configuration on carts and the Checkout integration are still in public beta. Any payment provider is connected through custom integration work.
Best for: large brands with an engineering team and a processor relationship already in place.
5. Shopify
Shopify is the fastest way to launch a standard store, but peptides run into its payment rules. The Shopify Payments eligibility list excludes pseudo-pharmaceuticals, described as products "that make health claims that are not verified" by a regulator, and lists prescription drugs among regulated products. Research peptides sold through Shopify therefore depend on a third-party processor.
As of November 2026, Shopify charges a third-party transaction fee of 2% on Basic ($29/month billed yearly), 1% on Grow ($79), 0.6% on Advanced ($299) and 0.2% on Plus (from $2,300/month) when you don't use Shopify Payments. A store can have only one credit card payment provider active at a time, so a processor termination leaves no card backup.
Shopify allows 2,048 variants and three options per product, and the free first-party Shopify Subscriptions app covers basic recurring orders. Subscriptions on Shopify require one of the gateways on its subscription gateway list: Shopify Payments, PayPal Express, Authorize.net, Adyen or Stripe. A high-risk processor outside that list rules out subscriptions. For a deeper look at Shopify's limits in this category, see our guide to the best Shopify alternatives for peptide brands.
Best for: cosmetic peptide skincare brands with conventional cosmetic claims that qualify for Shopify Payments. Research-peptide sellers should confirm processor approval first.
Reality Check: What No Platform Can Do for a Peptide Brand
- Approve your payments. The processor or acquiring bank decides whether to underwrite you and can review, reserve or close the account later. A platform only connects to the processor you've been approved by.
- Make research-use labeling hold up on its own. If your marketing, product names or support answers point to human use, a "not for human consumption" label doesn't change how FDA views the product.
- Make a product lawful. Platform terms, including Swell's, put legal compliance on the merchant. Rules vary by product and state, so check with counsel before you launch or add a SKU.
- Guarantee continuity. Even with two gateways configured, both depend on providers that can change their policies. Keep exports of customers, orders and subscriptions current.
How to Choose a Platform for Your Peptide Brand
| If you are... | Start with | Why |
|---|---|---|
| A research-peptide brand with a high-risk merchant account | Swell or WooCommerce | Run your acquirer through Authorize.Net or a custom integration, keep subscriptions native (Swell) or via extension (WooCommerce). |
| A cosmetic peptide skincare brand with cosmetic-only claims | Shopify, BigCommerce or Swell | Mainstream processors are more likely to approve; pick on subscriptions, catalog and design needs. |
| A hosted-platform shop that can use an embedded provider | BigCommerce | No Open Payment Provider fee with an embedded provider; subscriptions need an app. |
| An enterprise brand with an engineering team | commercetools or Swell | Both are API-first; commercetools is quote-only with 100 variants per product by default. |
| Running a 503A compounding pharmacy or telehealth program | Talk to counsel first | Prescriptions, state pharmacy licensing and processor rules for pharmacies drive the build, not the storefront. |
Whatever you choose, apply for the merchant account before you build the store, keep marketing copy consistent with how the product is labeled, and plan for a second processor from day one.
Start a Swell store with a 14-day free trial, no credit card required, and connect the gateway your processor has approved.
Frequently Asked Questions
What is the best ecommerce platform for peptide brands?
It depends on your processor. Research-peptide brands with a high-risk merchant account usually want a platform that can run that processor, keep a backup gateway and handle subscriptions natively; Swell and WooCommerce fit that, with BigCommerce an option if you can use an embedded provider or accept its Open Payment Provider fee. Cosmetic peptide skincare brands with cosmetic-only claims have more choice, including Shopify.
Can you sell peptides on Shopify?
Shopify Payments prohibits pseudo-pharmaceuticals and products with health claims that a regulator hasn't verified, so research-peptide sellers on Shopify depend on a third-party processor. That means a 0.2% to 2% third-party transaction fee by plan (as of November 2026), one credit card provider at a time, and subscriptions only through Shopify's supported gateway list.
Does Stripe allow peptide sales?
Stripe's restricted businesses list (updated September 22, 2026) doesn't name peptides. It prohibits "incorrectly labeled research chemicals" and pseudo-pharmaceuticals or nutraceuticals that are unsafe or make harmful claims, and restricts card-not-present prescription products. Cosmetic peptide skincare is generally a different case from research peptides. Ask Stripe for written confirmation before you launch.
Do I need a high-risk merchant account to sell peptides?
Most research-peptide sellers do, because mainstream processors exclude research chemicals, pseudo-pharmaceuticals or prescription products. A high-risk acquirer underwrites your business and issues a merchant account, which runs through a gateway such as Authorize.Net. Approval and terms are the provider's decision.
Is it legal to sell research peptides online?
FDA hasn't approved research peptides as drugs, and in 2026 warning letters it treated RUO peptides as unapproved new drugs when the seller's website showed they were intended for human use. State laws and shipping rules add more conditions. Whether a specific product and sales model is lawful is a question for counsel.
Does a "not for human consumption" label make research peptides compliant?
Not on its own. FDA's March and August 2026 warning letters looked past "research use only" labels to website content, product names and bundled bacteriostatic water. The label has to match how the product is actually marketed and sold.
What happened with BPC-157 and the FDA in 2026?
BPC-157 moved to FDA's "previously in category 2" list after its nominators withdrew it (page current as of April 22, 2026). The Pharmacy Compounding Advisory Committee reviewed it on July 23, 2026, and FDA's briefing proposed not adding it to the 503A bulks list. As of November 2, 2026, FDA hasn't published a decision.
Can I sell cosmetic peptide skincare on mainstream platforms?
Usually yes, if the claims are cosmetic. FDA classifies products by intended use, so drug-like claims can turn a serum into an unapproved drug. Cosmetics also fall under MoCRA facility registration and product listing, enforced since July 1, 2024.
Does Swell work with high-risk payment processors?
Swell's built-in card gateways are Stripe, Authorize.Net, Braintree, Saferpay and QuickPay. Authorize.Net can run on a merchant account from a provider that has approved your business. Processors such as NMI, PaymentCloud and Bankful aren't integrated; a developer can connect one of them through a Swell payment extension app, subject to that processor's own approval of your business. Swell doesn't approve payments, and approval is always the payment provider's decision.
Build your store on Swell
Headless commerce with a full API on every plan, native subscriptions and custom data models. Start a store and see how it fits your build.